The Ononin Diaries
RBP4 antagonists are at the moment below scientific trial to evaluate their efficacies in dealing with Stargardt sickness (STGD, an inherited problem that usually will cause vision loss in childhood or adolescence) [154]. The extensive-expression efficacy, toxicity and pharmacokinetic property will definitely guideline the applying of RBP4 antagoni